User profiles for "author:Valeria Raparelli"

Valeria Raparelli

Sapienza University of Rome
Verified email at uniroma1.it
Cited by 5740

Adherence to oral anticoagulant therapy in patients with atrial fibrillation

V Raparelli, M Proietti, R Cangemi… - Thrombosis and …, 2017 - thieme-connect.com
Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular
atrial fibrillation (NVAF) patients. Effective anticoagulation is important to avoid major …

[HTML][HTML] Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?

F Violi, S Basili, V Raparelli, P Chowdary, A Gatt… - Journal of …, 2011 - Elsevier
Patients with cirrhosis can have abnormalities in laboratory tests reflecting changes in
primary haemostasis, including bleeding time, platelet function tests, markers of platelet …

Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients

M Proietti, GF Romiti, V Raparelli, I Diemberger… - Ageing research …, 2022 - Elsevier
Frailty is a clinical syndrome characterized by a reduced physiologic reserve, increased
vulnerability to stressors and an increased risk of adverse outcomes. People with atrial …

Chronotype, gender and general health

F Fabbian, B Zucchi, A De Giorgi, R Tiseo… - Chronobiology …, 2016 - Taylor & Francis
Background: Light–dark alternation has always been the strongest external circadian
“zeitgeber” for humans. Due to its growing technological preference, our society is quickly …

Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy

L Palmieri, N Vanacore, C Donfrancesco… - The Journals of …, 2020 - academic.oup.com
Background Aim of the present study is to describe characteristics of COVID-19-related
deaths and to compare the clinical phenotype and course of COVID-19-related deaths …

Differential impact of heart failure with reduced ejection fraction on men and women

P Dewan, R Rørth, PS Jhund, L Shen… - Journal of the American …, 2019 - jacc.org
Background: Heart failure (HF) trials initiated in the last century highlighted many differences
between men and women. Of particular concern was undertreatment of women compared …

The importance of gender to understand sex differences in cardiovascular disease

PJ Connelly, Z Azizi, P Alipour, C Delles, L Pilote… - Canadian Journal of …, 2021 - Elsevier
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
There is robust evidence of heterogeneity in underlying mechanism, manifestation …

[PDF][PDF] Low‐grade endotoxemia and platelet activation in cirrhosis

V Raparelli, S Basili, R Carnevale, L Napoleone… - …, 2017 - Wiley Online Library
Patients with cirrhosis may display impaired or enhanced platelet activation, but the reasons
for these equivocal findings are unclear. We investigated if bacterial lipopolysaccharide …

Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis

L Alon, B Corica, V Raparelli, R Cangemi… - European Journal of …, 2022 - academic.oup.com
Aims Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent disease and has been
repeatedly associated with an increased risk of cardiovascular disease. However, the extent …

Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry

F Violi, RG Corazza, SH Caldwell, F Perticone… - Internal and emergency …, 2016 - Springer
Portal vein thrombosis may occur in cirrhosis; nevertheless, its prevalence, and predictors
are still elusive. To investigate this issue, the Italian Society of Internal Medicine undertook …